Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety Analysis of Oxaliplatin-based Chemotherapy for Advanced Gastric Cancer.
Inadomi K, Kusaba H, Matsushita Y, Tanaka R, Mitsugi K, Arimizu K, Hirano G, Makiyama A, Ohmura H, Uchino K, Hanamura F, Shibata Y, Kuwayama M, Esaki T, Takayoshi K, Arita S, Ariyama H, Akashi K, Baba E. Inadomi K, et al. Among authors: arimizu k. Anticancer Res. 2017 May;37(5):2663-2671. doi: 10.21873/anticanres.11614. Anticancer Res. 2017. PMID: 28476842 Clinical Trial.
Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer.
Makiyama A, Arimizu K, Hirano G, Makiyama C, Matsushita Y, Shirakawa T, Ohmura H, Komoda M, Uchino K, Inadomi K, Arita S, Ariyama H, Kusaba H, Shinohara Y, Kuwayama M, Kajitani T, Oda H, Esaki T, Akashi K, Baba E. Makiyama A, et al. Among authors: arimizu k. Gastric Cancer. 2018 May;21(3):464-472. doi: 10.1007/s10120-017-0759-9. Epub 2017 Aug 10. Gastric Cancer. 2018. PMID: 28799048
Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin.
Tsuchihashi K, Kusaba H, Yoshihiro T, Fujiwara T, Setsu N, Endo M, Matsumoto Y, Imajima T, Shinohara Y, Ito M, Yamaga S, Tanoue K, Arimizu K, Ohmura H, Hanamura F, Yamaguchi K, Isobe T, Ariyama H, Nakashima Y, Akashi K, Baba E. Tsuchihashi K, et al. Among authors: arimizu k. Sci Rep. 2020 Dec 1;10(1):20896. doi: 10.1038/s41598-020-77898-y. Sci Rep. 2020. PMID: 33262403 Free PMC article.
Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.
Tsuchihashi K, Ito M, Arita S, Kusaba H, Kusano W, Matsumura T, Kitazono T, Ueno S, Taguchi R, Yoshihiro T, Doi Y, Arimizu K, Ohmura H, Kajitani T, Nio K, Nakano M, Oshima K, Tamura S, Shirakawa T, Shimokawa H, Uchino K, Hanamura F, Okumura Y, Komoda M, Isobe T, Ariyama H, Esaki T, Hashimoto K, Komune N, Matsuo M, Matsumoto K, Asai K, Yoshitake T, Yamamoto H, Oda Y, Akashi K, Baba E. Tsuchihashi K, et al. Among authors: arimizu k. BMC Cancer. 2023 Oct 31;23(1):1046. doi: 10.1186/s12885-023-11528-4. BMC Cancer. 2023. PMID: 37904096 Free PMC article.
Lymphoproliferative Disorder in an Esophageal Cancer Patient Treated with Pembrolizumab.
Matsumura T, Tsuchihashi K, Yamamoto T, Jinnouchi F, Kusano W, Kusumoto Y, Arimizu K, Ohmura H, Kuma Y, Moriyama S, Yamaguchi K, Ito M, Isobe T, Ariyama H, Oda Y, Akashi K, Baba E. Matsumura T, et al. Among authors: arimizu k. Intern Med. 2024 Oct 18. doi: 10.2169/internalmedicine.3743-24. Online ahead of print. Intern Med. 2024. PMID: 39428537 Free article.
Development of an application for management of drug holidays in perioperative periods.
Kimura S, Emoto A, Yoshimura M, Arimizu K, Kamura T, Sogawa R, Mizuta K, Tagomori Y, Natsuaki M, Kajiwara M, Tsuruoka N, Yakushiji Y, Tanigawa Y, Takamatsu C, Danjo A, Kamohara K, Hirakawa N, Sakaguchi Y, Noguchi M, Noshiro H, Kawaguchi A, Sueoka E, Narisawa Y, Kimura S. Kimura S, et al. Among authors: arimizu k. Medicine (Baltimore). 2020 May;99(19):e20142. doi: 10.1097/MD.0000000000020142. Medicine (Baltimore). 2020. PMID: 32384497 Free PMC article.